CERE — Cerevel Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Veeva systems, Alphabet, Moderna
Abbvie to focus on smaller deals after Cerevel and ImmunoGen buyout (updated)
Abbvie to focus on smaller deals after Cerevel and ImmunoGen buyout
Deals of the day-Mergers and acquisitions
Cerevel options trading surge before AbbVie deal news raises eyebrows
U.S. STOCKS ON THE MOVE-Dollar General, J.B. Hunt, Bristol-Myers
Brief: Cerevel Therapeutics Holdings Says Under Deal, Co May Be Required To Pay Abbvie A Termination Fee Of Approximately $283.1 Mln
Newscasts - U.S. Morning Call: Senate Republicans block Ukraine, Israel aid bill over border dispute
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Semtech, AerSale
Deals of the day-Mergers and acquisitions
Cerevel Therapeutics rises on $8.7 bln buyout deal by AbbVie
U.S. RESEARCH ROUNDUP- Boeing, McDonald's, Quaker Houghton
Press Digest: Wall Street Journal - Dec. 7
Cerevel options trading surge before AbbVie deal news raises eyebrows
Cerevel jumps on Abbvie's $8.7 bln buyout deal
AbbVie to buy drug developer Cerevel for $8.7 billion (updated)
AbbVie to buy drug developer Cerevel for $8.7 billion
Brief: Abbvie To Acquire Cerevel Therapeutics In Transformative Transaction To Strengthen Neuroscience Pipeline
AbbVie nears roughly $8 billion deal for drug developer Cerevel-sources